TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $826,478 | -67.9% | 98,861 | -4.6% | 0.00% | -80.0% |
| Q2 2023 | $2,572,828 | +67.2% | 103,576 | +1.3% | 0.01% | +66.7% |
| Q1 2023 | $1,538,366 | +31.9% | 102,285 | +3.7% | 0.00% | +50.0% |
| Q4 2022 | $1,166,308 | +98.4% | 98,589 | -0.7% | 0.00% | +100.0% |
| Q3 2022 | $588,000 | +36.7% | 99,248 | -1.9% | 0.00% | 0.0% |
| Q2 2022 | $430,000 | -60.1% | 101,166 | -10.8% | 0.00% | -50.0% |
| Q1 2022 | $1,078,000 | -49.5% | 113,353 | +0.9% | 0.00% | -50.0% |
| Q4 2021 | $2,135,000 | -42.9% | 112,366 | -0.0% | 0.00% | -50.0% |
| Q3 2021 | $3,741,000 | -16.5% | 112,396 | -2.7% | 0.01% | -11.1% |
| Q2 2021 | $4,482,000 | -22.5% | 115,543 | -3.7% | 0.01% | -30.8% |
| Q1 2021 | $5,782,000 | -9.9% | 119,958 | -2.8% | 0.01% | -18.8% |
| Q4 2020 | $6,419,000 | +101.6% | 123,393 | +3.7% | 0.02% | +77.8% |
| Q3 2020 | $3,184,000 | +29.9% | 118,993 | -5.4% | 0.01% | +12.5% |
| Q2 2020 | $2,451,000 | +87.8% | 125,800 | -5.1% | 0.01% | +33.3% |
| Q1 2020 | $1,305,000 | -26.7% | 132,623 | -17.3% | 0.01% | 0.0% |
| Q4 2019 | $1,781,000 | +106.4% | 160,449 | +4.4% | 0.01% | +100.0% |
| Q3 2019 | $863,000 | -35.2% | 153,704 | -0.2% | 0.00% | -40.0% |
| Q2 2019 | $1,332,000 | +0.8% | 153,946 | -6.4% | 0.01% | 0.0% |
| Q1 2019 | $1,322,000 | +124.8% | 164,479 | +14.7% | 0.01% | +66.7% |
| Q4 2018 | $588,000 | -27.9% | 143,340 | -1.5% | 0.00% | -25.0% |
| Q3 2018 | $815,000 | -57.0% | 145,595 | +0.9% | 0.00% | -60.0% |
| Q2 2018 | $1,897,000 | -3.9% | 144,236 | +3.7% | 0.01% | -9.1% |
| Q1 2018 | $1,975,000 | +74.0% | 139,071 | +0.5% | 0.01% | +57.1% |
| Q4 2017 | $1,135,000 | +18.1% | 138,384 | +70.6% | 0.01% | +16.7% |
| Q3 2017 | $961,000 | +94.5% | 81,104 | +65.0% | 0.01% | +100.0% |
| Q2 2017 | $494,000 | -7.1% | 49,146 | -18.6% | 0.00% | -25.0% |
| Q1 2017 | $532,000 | +272.0% | 60,406 | +95.9% | 0.00% | +300.0% |
| Q4 2016 | $143,000 | – | 30,838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |